Xu Youyao, Chen Yizhen, Tang Xiaoyan
Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Hangzhou Medical College, Hangzhou, Zhejiang, China.
Glob Health Med. 2020 Apr 30;2(2):66-72. doi: 10.35772/ghm.2020.01015.
With the deepening of the understanding and research in coronavirus disease 2019 (COVID-19), the diagnosis and treatment of COVID-19 have been constantly updated and improved. In China, since the implementation of "Guidelines for the Diagnosis and Treatment of COVID-19 (1 Trial Version)" on Jan. 15, 2020, 2 to 7 versions (including revision of 5 version) was updated from Jan. 18, Jan. 22, Jan. 27, Feb. 4, Feb. 8, Feb. 18 and Mar. 3, respectively. Versions updated subsequently provide more detailed information in many ways than the 1 and 2 versions, so this paper will introduce the development of the main contents of the 3 to 7 versions of COVID-19 guidelines in China, which hopes to provide help for clinical medical staff in other countries fighting with this disease.
随着对2019冠状病毒病（COVID-19）认识和研究的不断深入，COVID-19的诊断和治疗也在不断更新和完善。在中国，自2020年1月15日实施《新型冠状病毒肺炎诊疗方案（试行第一版）》以来，分别于1月18日、1月22日、1月27日、2月4日、2月8日、2月18日及3月3日更新了2至7版（含5版修订版）。后续更新的版本在很多方面比第一版和第二版提供了更详细的信息，因此本文将介绍中国COVID-19诊疗方案3至7版主要内容的演变，希望能为其他国家抗击该疾病的临床医务人员提供帮助。
